Viewing Study NCT01148095


Ignite Creation Date: 2025-12-24 @ 1:19 PM
Ignite Modification Date: 2026-02-07 @ 8:25 PM
Study NCT ID: NCT01148095
Status: COMPLETED
Last Update Posted: 2011-02-08
First Post: 2010-06-18
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: To Investigate the Safety, Tolerability and Pharmacokinetics of AZD2516 After Multiple Dosing in Healthy Volunteers
Sponsor: AstraZeneca
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Part A Healthy Young Males and Non-fertile Female Volunteers Aged … View
None Part B Healthy Young Males and Non-fertile Female Volunteers Aged … View
Keywords:

Keywords

Keyword Brief Keyword Text View
None AZD2516 View
None Phase 1 View
None Healthy volunteer View
None pharmacokinetics View
None safety View
None tolerability View
None Multiple ascending doses View